TrialJAMA oncology2024

Response to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer: 5-year Follow-Up of a Phase 2 Clinical Trial.

Andrew B Katims et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.